Glucagon and Shock - a phase IV clinical study of FDA data

Summary:

Shock is reported as a side effect among people who take Glucagon (glucagon hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Hypotension.

The phase IV clinical study analyzes which people have Shock when taking Glucagon. It is created by eHealthMe based on reports of 4,289 people who have side effects when taking Glucagon from the FDA, and is updated regularly.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,222 drugs and 1,753 conditions by eHealthMe. Check the latest studies of Shock.

On Jul, 11, 2026

4,289 people reported to have side effects when taking Glucagon.
Among them, 64 people (1.49%) have Shock.

Among these 64 people:

How long have people been on Glucagon when they have Shock? *

What is the gender of people who have Shock when taking Glucagon? *

female: 75.41 %
male: 24.59 %

What is the age of people who have Shock when taking Glucagon? *

What are other drugs people take besides Glucagon? *

What are other side effects people have besides Shock? *

Hypotension (abnormally low blood pressure): 38 people, 59.38%
Overdose: 27 people, 42.19%
Cardiogenic Shock (inadequate circulation of blood): 27 people, 42.19%
Arrhythmias (irregular heartbeat): 23 people, 35.94%
Anuria (failure of the kidneys to produce urine): 22 people, 34.38%
Pulmonary Oedema (fluid accumulation in the lungs): 21 people, 32.81%
Hypokalemia (low potassium): 19 people, 29.69%
Circulatory Collapse: 18 people, 28.12%
Hypoglycemia (low blood sugar): 18 people, 28.12%
Depressed Level Of Consciousness: 18 people, 28.12%

What are the existing conditions these people have? *

Hypotension (abnormally low blood pressure): 7 people, 10.94%
Bradycardia (abnormally slow heart action): 6 people, 9.38%
Acute Myocardial Infarction (acute heart attack): 4 people, 6.25%
Delayed Recovery From Anaesthesia: 3 people, 4.69%
Completed Suicide (act of taking one's own life): 3 people, 4.69%
Cardiogenic Shock (inadequate circulation of blood): 3 people, 4.69%
High Blood Pressure: 3 people, 4.69%
Blood Pressure Abnormal: 3 people, 4.69%
Sedation: 3 people, 4.69%
Overdose: 2 people, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and have Shock?

- Check whether Shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucagon:

Glucagon (4,297 reports)

Shock treatments and more:

Shock (28,534 reports)

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock:

Shock (1,222 drugs)

Browse all the conditions that are associated with Shock:

Shock (1,753 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride (the active ingredients of Glucagon) and Glucagon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.